As of 2024-12-14, the Relative Valuation of Briacell Therapeutics Corp (BCT.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 CAD, the upside of Briacell Therapeutics Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-03 | -12.23 |
| 2024-12-02 | -11.78 |
| 2024-11-29 | -10.35 |
| 2024-11-28 | -9.06 |
| 2024-11-27 | -9.14 |
| 2024-11-26 | -7.55 |
| 2024-11-25 | -7.10 |
| 2024-11-22 | -7.63 |
| 2024-11-21 | -8.23 |
| 2024-11-20 | -6.42 |
| 2024-11-19 | -6.04 |
| 2024-11-18 | -6.19 |
| 2024-11-15 | -6.27 |
| 2024-11-14 | -6.34 |
| 2024-11-13 | -6.34 |
| 2024-11-12 | -6.72 |
| 2024-11-11 | -6.80 |
| 2024-11-08 | -7.55 |
| 2024-11-07 | -7.33 |
| 2024-11-06 | -7.33 |
| 2024-11-05 | -7.48 |
| 2024-11-04 | -8.08 |
| 2024-11-01 | -8.31 |
| 2024-10-31 | -8.76 |
| 2024-10-30 | -7.70 |
| 2024-10-29 | -8.91 |
| 2024-10-28 | -9.14 |
| 2024-10-25 | -9.06 |
| 2024-10-24 | -9.36 |
| 2024-10-23 | -9.59 |
| 2024-10-22 | -9.36 |
| 2024-10-21 | -8.38 |
| 2024-10-18 | -8.76 |
| 2024-10-17 | -8.76 |
| 2024-10-16 | -8.53 |
| 2024-10-15 | -9.44 |
| 2024-10-11 | -10.12 |
| 2024-10-10 | -10.35 |
| 2024-10-09 | -9.67 |
| 2024-10-08 | -11.18 |
| 2024-10-07 | -10.95 |
| 2024-10-04 | -10.19 |
| 2024-10-03 | -9.74 |
| 2024-10-02 | -10.04 |
| 2024-10-01 | -8.08 |
| 2024-09-30 | -12.31 |
| 2024-09-27 | -7.93 |
| 2024-09-26 | -7.40 |
| 2024-09-25 | -7.70 |
| 2024-09-24 | -6.57 |